Strategy and planning for chemopreventive drug development: Clinical development plans II (pages 54–71)Gary J. Kelloff, James A. Crowell, Ernest T. Hawk, Vernon E. Steele, Ronald A. Lubet, Charles W. Boone, Joseph M. Covey, Linda A. Doody, Gilbert S. Omenn, Peter Greenwald, Waun K. Hong, David R. Parkinson, Donya Bagheri, Gregory T. Baxter, Margaret Blunden, Mary K. Doeltz, Karen M. Eisenhauer, Karen Johnson, Gene G. Knapp, David G. Longfellow, Winfred F. Malone, Susan G. Nayfield, Harold E. Seifried, Leah M. Swall and Caroline C. Sigman
Article first published online: 12 MAY 2005 | DOI: 10.1002/jcb.240630705